ABSTRACT
Psychiatric disorders and psychological problems are common in patients with diabetes mellitus. There is a twofold increase in depression which is associated with suboptimal glycemic control and increased morbidity and mortality. Other psychiatric disorders with a higher incidence of diabetes are cognitive impairment, dementia, disturbed eating behavior, anxiety disorders, schizophrenia, bipolar disorders and borderline personality disorder. The coincidence of mental disorders and diabetes has unfavorable influences on metabolic control and micro- and macroangiopathic complications. Improvement of therapeutic outcome is a challenge in the modern health care system. The intentions behind this position paper are to rise awareness of this special set of problems, to intensify cooperation between involved health care providers and to reduce incidence of diabetes mellitus as well as morbidity and mortality from diabetes in this patient group.
Subject(s)
Diabetes Mellitus , Mental Disorders , Schizophrenia , Humans , Mental Disorders/diagnosis , Mental Disorders/epidemiology , Mental Disorders/therapy , Diabetes Mellitus/epidemiology , Diabetes Mellitus/therapy , Anxiety Disorders , IncidenceABSTRACT
Psychiatric disorders and psychological problems are common in patients with diabetes mellitus. There is a twofold increase in depression which is associated with suboptimal glycemic control and increased morbidity and mortality. Other psychiatric disorders with a higher incidence of diabetes mellitus are cognitive impairment, dementia, disturbed eating behavior, anxiety disorders, schizophrenia, bipolar disorders and borderline personality disorder. The coincidence of mental disorders and diabetes mellitus has unfavorable influences on metabolic control and micro- and macroangiopathic complications. Improvement of therapeutic outcome is a challenge in the modern health care system. The intentions behind this position paper are to rise awareness of this special set of problems, to intensify cooperation between involved health care providers and to reduce incidence of diabetes mellitus as well as morbidity and mortality from diabetes in this patient group.
Subject(s)
Diabetes Mellitus , Mental Disorders , Practice Guidelines as Topic , Anxiety Disorders , Dementia , Diabetes Complications , Diabetes Mellitus/drug therapy , Diabetes Mellitus/psychology , Humans , Hypoglycemic Agents , Medication Adherence/psychology , Mental Disorders/drug therapy , Mental Disorders/psychology , Treatment OutcomeABSTRACT
Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR encephalitis) is a rare and recently discovered disease. Affected patients are initially often referred to psychiatric departments due to prominent neuropsychiatric symptoms.We present the course of the illness of an 18-year-old female patient, who was primarily and for the first time admitted to the 1. Psychiatric Department of the Otto Wagner Hospital Vienna due to a psychotic disorder. With fluctuating clinical course, further diagnostics were performed and the patient was diagnosed with anti-NMDAR encephalitis.Anti-NMDAR encephalitis should especially be considered in young women, who suffer from a first-onset psychotic disorder in combination with neurological and vegetative symptoms.If suspected lumbar puncture is indicated. An interdisciplinary approach is indispensable for this disease and can be a challenge for psychiatrists in charge.Psychiatrists should consider encephalitis, autoimmune encephalitis in particular, as differential diagnosis in clinical practice and get more familiar with these complex conditions.
Subject(s)
Anti-N-Methyl-D-Aspartate Receptor Encephalitis/diagnosis , Psychotic Disorders/diagnosis , Adolescent , Diagnosis, Differential , Diagnostic Errors , Female , HumansABSTRACT
Psychiatric disorders and psychological problems are common in patients with diabetes mellitus. There is a twofold increase in depression which is associated with suboptimal glycemic control and increased morbidity and mortality. Other psychiatric disorders with a higher incidence of diabetes mellitus are cognitive impairment, dementia, disturbed eating behaviour, anxiety disorders, schizophrenia, bipolar disorders and borderline personality disorder. The coincidence of mental disorders and diabetes mellitus has unfavourable influences on metabolic control and micro- and macroangiopathic late complications. Improvement of therapeutic outcome is a challenge in the modern health care system. The intentions behind this position paper are to rise awareness of this special set of problems, to intensify cooperation between involved health care providers and to reduce incidence of diabetes mellitus as well as morbidity and mortality from diabetes in this patient group.
Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/psychology , Medication Adherence/psychology , Mental Disorders/psychology , Mental Disorders/therapy , Practice Guidelines as Topic , Austria , Diabetes Mellitus, Type 2/diagnosis , Dose-Response Relationship, Drug , Drug Administration Schedule , Evidence-Based Medicine , Humans , Hypoglycemic Agents/administration & dosage , Mental Disorders/diagnosis , Treatment OutcomeABSTRACT
Psychiatric disorders and psychological problems are common in patients with diabetes mellitus. There is a twofold increase in depression which is associated with suboptimal glycemic control and increased morbidity and mortality. Other psychiatric disorders frequently associated with diabetes mellitus are disturbed eating behaviour, anxiety disorders, schizophrenia and borderline disease. The coincidence of mental disorders and diabetes mellitus has unfavourable influences on metabolic control and micro- and macroangiopathic late complications. Improvement of therapeutic outcome is a challenge in the modern health system. The intentions behind this position paper are to rise awareness of this special set of problems, to intensify cooperation between involved health care providers and to reduce morbidity and mortality in this patient group.
